ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2007–2024

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2024	—	5	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	5	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	4	1
2012	—	4	1
2011	—	5	1
2010	—	4	1
2009	—	4	1
2008	—	5	1
2007	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
HPS GROUP, LLC	—	74

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	73
SENATE	73
Health & Human Services, Dept of (HHS)	69
Office of Management & Budget (OMB)	68
Food & Drug Administration (FDA)	8
UNDETERMINED	2
Executive Office of the President (EOP)	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Budget/Appropriations	Budget/Appropriations	74

ALLIANCE FOR A STRONGER FDA (FORMERLY FDA ALLIANCE) — Lobbying Disclosure | Poliscope